enow.com Web Search

  1. Ad

    related to: new peptides for dementia therapy and wellness

Search results

  1. Results from the WOW.Com Content Network
  2. J147 - Wikipedia

    en.wikipedia.org/wiki/J147

    J147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. [1] [2] [3] [4]The approach that lead to development of the J147 drug was to screen candidate molecules for anti-aging effects, instead of targeting the amyloid plaques.

  3. 22 health care predictions for 2025 from medical researchers

    www.aol.com/news/22-health-care-predictions-2025...

    2024 was packed with health care innovations, from a new blood test detecting Alzheimer’s disease to deep brain stimulation reversing paralysis. Heading into the New Year, medical experts are ...

  4. Cerebrolysin - Wikipedia

    en.wikipedia.org/wiki/Cerebrolysin

    Cerebrolysin (developmental code name FPF-1070) is an experimental mixture of enzymatically-treated peptides derived from pig brain whose constituents can include brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF).

  5. Taking This Daily Vitamin Could Slash Dementia Risk By 40 ...

    www.aol.com/taking-daily-vitamin-could-slash...

    $20.99 at Amazon. Orange Vitamin D3. Rated at 4.7 stars by over 6,000 happy customers on Amazon, this daily vitamin is a tried-and-true product that's affordable and even offers a refreshing ...

  6. Dihexa - Wikipedia

    en.wikipedia.org/wiki/Dihexa

    Dihexa (developmental code PNB-0408; also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met.

  7. Dementia Doctors Share The Changes They Would Make ... - AOL

    www.aol.com/dementia-doctors-share-changes-today...

    Moderate and severe traumatic brain injuries increase a risk of cognitive decline or dementia even years later by anywhere from two to four times, according to the Alzheimer’s Association. For ...

  8. A Common Drug Could Lower Your Dementia Risk By 35 ... - AOL

    www.aol.com/common-drug-could-lower-dementia...

    After 670 days, there were 1,172 new diagnoses of dementia among the study participants. When compared with people who took DPP-4 inhibitors, those who took SGLT-2 inhibitors had a 35 percent ...

  9. Amyloid beta - Wikipedia

    en.wikipedia.org/wiki/Amyloid_beta

    Amyloid beta (Aβ, Abeta or beta-amyloid) denotes peptides of 36–43 amino acids that are the main component of the amyloid plaques found in the brains of people with Alzheimer's disease. [2] The peptides derive from the amyloid-beta precursor protein (APP), which is cleaved by beta secretase and gamma secretase to yield Aβ in a cholesterol ...

  1. Ad

    related to: new peptides for dementia therapy and wellness